The Innovative Medicines Initiative (IMI) is Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI has launched IMI2 – Call 12, with topics on Alzheimer, data, Sjögren’s Syndrome, vaccines, the blood-brain barrier, & a European Screening Centre.
Stage 1 submission deadline: 24 October 2017
Stage 2 submission deadline: 16 May 2018
Proposals must be submitted via the electronic submission system of the Horizon 2020 Participant Portal.
Detailed information: https://www.imi.europa.eu/content/imi2-call-12
If you want to apply to take part in a new IMI project, you need to find or build an applicant consortium, and to do this, you will need to find partners.
https://www.imi.europa.eu/content/partner-search page provides some tips on how to go about this.